Article ISI SCOPUS
JOURNAL OF CLINICAL EPIDEMIOLOGY  (2017)

Latin American Clinical Epidemiology Network Series - Paper 2: Apixaban was cost-effective vs. acenocoumarol in patients with nonvalvular atrial fibrillation with moderate to severe risk of embolism in Chile

Más información

Título según WOS: Latin American Clinical Epidemiology Network Series - Paper 2: Apixaban was cost-effective vs. acenocoumarol in patients with nonvalvular atrial fibrillation with moderate to severe risk of embolism in Chile
Título según SCOPUS: Latin American Clinical Epidemiology Network Series – Paper 2: Apixaban was cost-effective vs. acenocoumarol in patients with nonvalvular atrial fibrillation with moderate to severe risk of embolism in Chile
Título de la Revista: JOURNAL OF CLINICAL EPIDEMIOLOGY
Volumen: 86
Editorial: Elsevier Science Inc.
Fecha de publicación: 2017
Página de inicio: 75
Página final: 83
Idioma: English
DOI:

10.1016/j.jclinepi.2016.05.018
Notas: ISI, SCOPUS